Moderna raises 2026 revenue-growth outlook to 15%–25%
Moderna raised its full-year 2026 revenue-growth outlook to 15%–25%, from 10% previously. The company reported third-quarter revenue of $1.3 billion, up 29%, and adjusted earnings of 38 cents per share, compared with FactSet estimates of $890 million in revenue and a loss of 80 cents per share.